bluebird bio Inc (BLUE)
0.5044
+0.01
(+1.39%)
USD |
NASDAQ |
Sep 27, 16:00
0.5045
0.00 (0.00%)
After-Hours: 20:00
bluebird bio SG&A Expense (TTM): 174.48M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 174.48M |
December 31, 2023 | 165.62M |
September 30, 2023 | 152.64M |
June 30, 2023 | 145.34M |
March 31, 2023 | 141.69M |
December 31, 2022 | 140.33M |
September 30, 2022 | 159.41M |
June 30, 2022 | 168.24M |
March 31, 2022 | 186.52M |
December 31, 2021 | 213.99M |
September 30, 2021 | 190.81M |
June 30, 2021 | 216.63M |
March 31, 2021 | 230.27M |
December 31, 2020 | 239.95M |
September 30, 2020 | 250.61M |
June 30, 2020 | 248.81M |
March 31, 2020 | 248.81M |
December 31, 2019 | 235.84M |
September 30, 2019 | 248.67M |
June 30, 2019 | 226.94M |
March 31, 2019 | 199.48M |
December 31, 2018 | 174.13M |
September 30, 2018 | 149.71M |
Date | Value |
---|---|
June 30, 2018 | 128.16M |
March 31, 2018 | 108.19M |
December 31, 2017 | 93.55M |
September 30, 2017 | 80.64M |
June 30, 2017 | 72.28M |
March 31, 2017 | 69.45M |
December 31, 2016 | 65.12M |
September 30, 2016 | 63.38M |
June 30, 2016 | 62.47M |
March 31, 2016 | 54.83M |
December 31, 2015 | 46.21M |
September 30, 2015 | 37.07M |
June 30, 2015 | 30.01M |
March 31, 2015 | 25.02M |
December 31, 2014 | 23.23M |
September 30, 2014 | 22.61M |
June 30, 2014 | 19.80M |
March 31, 2014 | 17.34M |
December 31, 2013 | 14.13M |
September 30, 2013 | 11.98M |
June 30, 2013 | 9.757M |
March 31, 2013 | 7.807M |
December 31, 2012 | 6.846M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
140.33M
Minimum
Dec 2022
250.61M
Maximum
Sep 2020
197.82M
Average
190.81M
Median
Sep 2021
SG&A Expense (TTM) Benchmarks
Vertex Pharmaceuticals Inc | 1.348B |
Perspective Therapeutics Inc | 18.64M |
Protalix BioTherapeutics Inc | 14.41M |
Predictive Oncology Inc | 10.73M |
Spectral AI Inc | 21.85M |